Work

Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors

Year: 2023

Type: article

Source: Current Cancer Drug Targets

DOI: 10.2174/1568009623666230209121732

Authors: Fine Aliyuda, Michele Moschetta, Aruni Ghose, Kathrine Sofia Rallis, Matin Sheriff, Elisabet Sanchez, Elie Rassy, Stergios Boussios

Institutions: Medway NHS Foundation Trust, Novartis (Switzerland), Novartis Institutes for BioMedical Research, St Bartholomew's Hospital, Barts Health NHS Trust, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Beth Israel Deaconess Medical Center, Queen Mary University of London, Barts Cancer Institute, Institut Gustave Roussy, King's College London

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4319657142

FWCI: 13.29

Cites: 106

Cited by: 105

Related to: 10